GlassScriptPhysician profile
Reema Batra
NPI 1629286505
$76,476.30
in general payments reported to CMS, 2019-2025
85 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,374 · 2021: $10K · 2022: $9,584 · 2023: $11K · 2024: $14K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $11K · Consulting Fee: $3,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,614.00 |
| Food and Beverage | $11,035.04 |
| Consulting Fee | $3,952.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $59,996.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,582.09 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Daiichi Sankyo INC. | $2,316.25 | 2020-2025 | Enhertu, Injectafer, Vanflyta |
| Novartis Pharmaceuticals Corporation | $820.74 | 2019-2025 | |
| Pfizer INC. | $661.19 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $630.54 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $562.93 | 2019-2025 | Reblozyl, Breyanzi, Opdualag |
| Pharmacyclics LLC, An Abbvie Company | $496.29 | 2019-2023 | Imbruvica |
| Janssen Biotech, INC. | $383.66 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Incyte Corporation | $334.94 | 2019-2025 | Jakafi, Monjuvi |
| Eisai INC. | $330.76 | 2019-2025 | |
| Abbvie INC. | $329.35 | 2023-2025 | Venclexta |
| Astellas Pharma US INC | $288.67 | 2019-2025 | Padcev, Vyloy, Xospata |
| Glaxosmithkline, LLC. | $272.76 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Takeda Pharmaceuticals U.S.A., INC. | $262.88 | 2022-2025 | Ninlaro, Fruzaqla, Alunbrig |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $260.12 | 2019-2025 | Polivy, Lunsumio, Columvi |
| E.R. Squibb & Sons, L.L.C. | $246.36 | 2022-2025 | Opdivo, Opdualag |
| Amgen INC. | $237.69 | 2019-2023 | Blincyto, Kyprolis |
| Gilead Sciences, INC. | $220.26 | 2021-2025 | Trodelvy |
| Stemline Therapeutics INC. | $214.14 | 2023-2025 | Orserdu |
| Array Biopharma INC | $213.47 | 2021-2025 | Mektovi, Braftovi, Xalkori |
| Bayer Healthcare Pharmaceuticals INC. | $207.46 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $205.54 | 2021-2025 | Libtayo, Lynozyfic |
| Pharmaessentia USA Corporation | $200.18 | 2022-2025 | Besremi |
| Beigene USA, INC. | $192.57 | 2021-2025 | Brukinsa |
| Karyopharm Therapeutics INC. | $179.98 | 2020-2025 | Xpovio |
| Seagen INC. | $169.21 | 2022-2023 | Adcetris, Tukysa, Tivdak |
| Lilly USA, LLC | $168.06 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Alexion Pharmaceuticals, INC. | $150.90 | 2023-2024 | Ultomiris |
| Ipsen Biopharmaceuticals, INC | $148.89 | 2022-2025 | Onivyde, Somatuline Depot, Tazverik |
| Puma Biotechnology, INC. | $145.76 | 2022-2025 | |
| Sobi, INC | $145.71 | 2023-2025 | |
| Genmab U.S., INC. | $136.82 | 2023-2025 | Epkinly |
| Deciphera Pharmaceuticals INC. | $121.85 | 2023-2025 | Qinlock, Tgct, Romvimza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.00 | 2019-2025 | Gilotrif |
| Exelixis INC. | $112.44 | 2019-2025 | Cabometyx |
| Tersera Therapeutics LLC | $110.35 | 2023-2025 | Zoladex, Xermelo, Quzyttir |
| Rigel Pharmaceuticals, INC. | $109.48 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Aurinia Pharma U.S., INC. | $105.60 | 2024 | Lupkynis |
| Sumitomo Pharma America, INC. | $104.26 | 2023-2025 | Orgovyx |
| Adc Therapeutics America, INC. | $102.44 | 2023-2025 | |
| Coherus Oncology, INC. | $96.19 | 2023-2025 | Loqtorzi |
| Beone Medicines USA, INC. | $94.91 | 2025 | Brukinsa, Tevimbra |
| Sanofi-Aventis U.S. LLC | $83.33 | 2021 | |
| Springworks Therapeutics, INC. | $81.58 | 2024-2025 | Ogsiveo |
| Syndax Pharmaceuticals, INC. | $79.75 | 2025 | |
| Aveo Pharmaceuticals, INC. | $76.01 | 2022-2025 | Fotivda |
| Blueprint Medicines Corporation | $75.07 | 2023-2025 | Ayvakit |
| Adaptive Biotechnologies Corporation | $68.88 | 2023-2024 | Clonoseq |
| Pharmacosmos Therapeutics INC. | $68.66 | 2024-2025 | Monoferric |
| Mirati Therapeutics, INC. | $68.21 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $63.45 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $63.12 | 2024-2025 | Sylvant, Enjaymo |
| Acrotech Biopharma INC. | $61.63 | 2023-2024 | Beleodaq |
| Emd Serono, INC. | $61.11 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $53.77 | 2022-2025 | Givlaari, Amvuttra |
| Tempus Ai, INC | $53.28 | 2024-2025 | Xt Cdx |
| Taiho Oncology, INC. | $52.20 | 2022-2023 | |
| Novo Nordisk INC | $42.05 | 2023-2024 | Novoseven, Novoeight |
| Kyowa Kirin, INC. | $40.66 | 2019-2023 | Poteligeo |
| Morphosys, US INC. | $39.86 | 2022-2023 | Monjuvi |
| Fennec Pharmaceuticals, INC. | $39.41 | 2024-2025 | Fyarro, Pedmark |
| Janssen Pharmaceuticals, INC | $36.73 | 2019-2024 | Xarelto |
| Agios Pharmaceuticals, INC. | $36.67 | 2024-2025 | Pyrukynd |
| Dendreon Pharmaceuticals LLC | $33.79 | 2024 | Provenge |
| Geron Corporation | $31.26 | 2025 | Rytelo |
| Ge Healthcare | $30.80 | 2025 | |
| Amneal Pharmaceuticals LLC | $28.17 | 2025 | Pemrydi Rtu |
| Verastem, INC. | $26.41 | 2020 | |
| Accord Healthcare, INC. | $24.97 | 2025 | |
| Progenics Pharmaceuticals, INC. | $24.62 | 2024 | |
| Immunogen, INC. | $23.94 | 2023 | Elahere |
| Kite Pharma, INC. | $23.85 | 2025 | Yescarta |
| Iovance Biotherapeutics, INC. | $22.38 | 2025 | Amtagvi |
| Myovant Sciences INC. | $22.14 | 2021 | |
| Novocure INC. | $21.64 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $21.10 | 2019 | |
| Apellis Pharmaceuticals, INC. | $19.00 | 2023 | Empaveli |
| Menarini Silicon Biosystems, INC. | $18.50 | 2023 | Cellsearch |
| Immunocore Limited | $18.20 | 2024 | Kimmtrak |
| Sun Pharmaceutical Industries INC. | $18.09 | 2024 | |
| Heron Therapeutics, INC. | $13.63 | 2023 | Sustol |
| Foundation Medicine, INC. | $12.64 | 2021 | |
| Emmaus Medical, INC. | $8.89 | 2023 | Endari |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reema Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.